Google Alert - hepatitis c

[Guest guest]

News

9 new results for hepatitis c

Programs may curb hepatitis C in drug usersReuters IndiaBy Amy Norton NEW YORK (Reuters Health) - Programs that give injection drug users clean needles or safer drug substitutes may help cut their odds of contracting the liver infection hepatitis C, a new study suggests. The hepatitis C virus is passed ...See all stories on this topic »

Vertex Tops Merck in Early Hep C Drug LaunchTheStreet.com(TheStreet) -- Vertex Pharmaceuticals'(VRTX) new hepatitis C drug Incivek is outselling Victrelis, a rival drug from Merck(MRK), in the early weeks of their respective commercial launches. US regulators approved Incivek and Victrelis in May just 10 ...See all stories on this topic »

Will new drugs block hepatitis C virus in its tracks?EurekAlert (press release)Targeted multi-drug treatments for hepatitis C patients that could stop the virus in its tracks have come a step closer, thanks to researchers at the University of Leeds, UK. The study by Dr and colleagues, published in the journal ...See all stories on this topic »

SGT. SHAFT: Widow questions how vet caught hepatitis CWashington TimesJust like many, many soldiers receiving their immunizations from immunization guns, he was immunized with hepatitis C, which was passed from the immunization gun to each soldier. He also spoke of the unsafe practices in the military hospital he worked ...See all stories on this topic »

Washington Times

Vertex shares up as hep C sales outpace Merck'sBizjournals.comVertex Pharmaceuticals (Nasdaq: VRTX) shares were up more than 4 percent, Tuesday afternoon, on reports that have the Cambridge, Mass. biotech company's brand-new hepatitis C drug, Incivek, selling faster than a competing drug launched by Merck & Co. ...See all stories on this topic »

P7 protein resistance mutations identified; represent drug targets for ...EurekAlert (press release)British researchers have identified specific resistance mutations for two classes of p7 inhibitor, which may explain their lack of effectiveness in clinical trials combined with current standard of care. Study results support the role of p7 inhibitor ...See all stories on this topic »

Inhibition of cyclophilins alters lipid trafficking and blocks hepatitis C ...7thSpace Interactive (press release)Host cyclophilin (cyp) inhibitors, such as NIM811, efficiently inhibit replication of hepatitis C virus (HCV) and have shown significant promise in recent clinical trials for the treatment of chronic HCV. It is therefore important to fully understand ...See all stories on this topic »

Establishment of stable Huh-7 cell lines expressing various Hepatitis C Virus ...7thSpace Interactive (press release)Hepatitis C virus (HCV) infection is the leading cause of chronic hepatitis which progresses to hepatocellular carcinoma (HCC) afflicting >170 million people worldwide. HCV 3a is the most common genotype (about 70%

of all genotypes) circulating in ...See all stories on this topic »

Active hepatitis C infection and HCV genotypes prevalent among the IDUs of ...7thSpace Interactive (press release)Injection drug users (IDUs) are considered as a high risk group to develop hepatitis C due to needle sharing. In this study we have examined 200 injection drug users from various regions of the Khyber Pakhtunkhwa province for the prevalence of active ...See all stories on this topic »